Some benefits of FDA-approved GLP-1/GIP medications beyond weight loss are supported by emerging research and may vary based on individual health conditions, including: Improve blood sugar regulation, increase insulin sensitivity, and lower A1C Reduce long-term diabetic risks and protect pancreatic function Lower cholesterol, triglycerides, and blood pressure, supporting long-term cardiovascular health Show promising reductions in heart attacks and strokes in early studies Reduce liver fat and potentially improve metabolic fatty liver disease
This practice appears common without reported problems, though no formal stability data exists for the combined solution
Image: Bloomberg/Bloomberg via Getty Images/Bloomberg Eli Lilly, the drugmaker behind the blockbuster weight loss drug Zepbound, is suing four telehealth companies for allegedly selling illegal copies of the drug made by compounding pharmacies
Food and Drug Administration, the European Medicines Agency, or any other major regulator
Shortage information can be found on the FDAs shortage database or on the ASHP shortage list
many patients see 5 to 10 pounds in the first month and cumulative losses of 20 to 40 pounds by six months depending on adherence and baseline metabolism